Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) of Hansa Biopharma AB, effective July 14.

Centauri Therapeutics Limited, an immunotherapy company, has appointed Dr. Debra Barker as Chief Medical Officer (CMO).

Natoli Engineering's Precision CT Scan allows manufacturers to visualize internal tablet structures without cutting or ...

Körber’s Business Area Pharma now offers a standardized approach to connect systems and equipment to its market-leading PAS-X ...

Almac Clinical Services has completed a multi-million-dollar investment to enhance cold chain capabilities at its global ...

The CDMO has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line. As a ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Fujifilm’s FF-10832, an investigational liposomal formulation of gemcitabine, for the treatment of biliary tract ...

Biosynth, a developer and supplier of critical raw materials and services for life sciences and diagnostics, has opened an expanded GMP bioconjugation facility at its existing Berlin site.

Pace Life Sciences LLC is remodeling and expanding its Salem, NH, site to establish a Center of Excellence for Aseptic ...

Circio Holding ASA, a biotechnology company developing circular RNA technology for next generation nucleic acid medicine, has ...

The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Veranova has appointed Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides. Villain brings extensive ...